Huge congratulations to Magdalen Professorial Fellow of Engineering, Professor Constantin Coussios, on the continued success OrganOx, the Oxford spin-out he co-founded.
OrganOx has recently secured $142 million in investment to support expansion in the U.S. ahead of a potential public listing. The company’s technology, which keeps donated livers viable at body temperature, has been used in over 5,000 transplants.
Professor Constantin Coussios’ pioneering liver preservation technology is already saving lives worldwide. His work with OrganOx is not just a technological breakthrough – it is transforming transplant medicine. By securing this investment, OrganOx can expand its reach, bringing its pioneering organ preservation technology to even more patients globally.
We look forward to seeing the continued impact of this groundbreaking work in the years ahead as OrganOx expands its reach and advances transplant medicine.